Palo Alto Investors »

Bicycle Therapeutics shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 60k 22.63

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Biogen Idec (BIIB)
Staar Surgical Com Par $0.01 (STAA)
ACADIA Pharmaceuticals (ACAD)
Alnylam Pharmaceuticals (ALNY)
Prothena Corp SHS (PRTA)
Iovance Biotherapeutics (IOVA)
Anaptysbio Inc Common (ANAB)
Sarepta Therapeutics (SRPT)
Alkermes SHS (ALKS)
Ptc Therapeutics I (PTCT)
Align Technology (ALGN)

View all positions for Palo Alto Investors

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Deep Track Capital
Fcpm Iii Services B.v.
RA Capital Management
Armistice Capital
Westfield Capital Management Company
T. Rowe Price Associates
Tybourne Capital Management
Candriam Luxembourg S.C.A.
Polar Capital Holdings
First Light Asset Management
Camber Capital Management
EcoR1 Capital
Point72 Asset Management
Bnp Paribas Investment Partners

View all funds holding Bicycle Therapeutics